Antihyperglycaemic activity of ethylacetate extract of Chlorophytum alismifolium in type 2 diabetes:The involvement of peroxisome proliferator-activated receptor-γand dipeptidyl peptidase-4
Antihyperglycaemic activity of ethylacetate extract of Chlorophytum alismifolium in type 2 diabetes: The involvement of peroxisome proliferator-activated receptor-γ and dipeptidyl peptidase-4作者机构:Department of Pharmacology and TherapeuticsAhmadu Bello UniversityZaria PMB-1044Nigeria Department of Pharmacology and TherapeuticsBayero UniversityKano PMB-3011Nigeria Department of Human PhysiologyAhmadu Bello UniversityZaria PMB-1044Nigeria Department of Pharmacognosy and Drug DevelopmentAhmadu Bello UniversityZaria PMB-1044Nigeria
出 版 物:《Journal of Integrative Medicine》 (结合医学学报(英文版))
年 卷 期:2021年第19卷第1期
页 面:78-84页
核心收录:
学科分类:1008[医学-中药学(可授医学、理学学位)] 1006[医学-中西医结合] 100602[医学-中西医结合临床] 10[医学]
基 金:Department of Human Anatomy Ahmadu Bello University, ABU
主 题:Chlorophytum alismifolium Diabetes mellitus Gas chromatography-mass spectrometry Insulin Peroxisome proliferator-activated receptor-c Dipeptidyl-peptidase 4
摘 要:Objective:This research is to investigate the antihyperglycaemic activity and the underlying mechanisms of action of the ethylacetate extract of Chlorophytum alismifolium(EACA)tubers in a type 2 diabetes ***:The tubers were processed and sequentially extracted in hexane followed by ethylacetate,using a Soxhlet apparatus,and subjected to gas chromatography-mass spectrometry(GC–MS).The acute toxicity of EACA was investigated in albino Wistar *** antihyperglycaemic study was carried out using high-fat diet(pelletized diet and margarine in the ratio of 10:1 and 20%fructose solution)and streptozotocin-induced hyperglycaemic Wistar *** effects of the extract(150,300 and 600 mg/kg)on blood glucose level,insulin,peroxisome proliferator-activated receptor-c(PPAR-c)and dipeptidyl peptidase-4(DPP-4)were evaluated using enzyme-linked immunosorbent ***:The oral median lethal dose in Wistar rats was estimated to be5000 mg/*** with EACA at all doses significantly reduced the fasting blood glucose levels,compared to the hyperglycaemic control,and over *** of EACA increased the serum insulin and PPAR-c levels while decreasing DPP-4 ***–MS analysis revealed the presence of 13 compounds,with isothiazole and isoxazolidine covering total area of 24.6%and 22.69%,***:The findings from this study showed that EACA has important compounds with beneficial effect in type 2 diabetes and acts by increasing insulin secretion and PPAR-c level and decreasing DPP-4 activity.